News and Announcements
Executive Director of Alcidion to Present at BioShares Biotech Summit
- Published July 26, 2016 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
26th July 2016, ASX Announcement
Alcidion Group Limited (ASX: ALC) is pleased to announce that Executive Director, Mr Nathan Buzza, will present a paper on “Opportunities for Investment in Digital Health” at the Bioshares Biotech Summit on July 29th 2016 in Queenstown, New Zealand.
A copy of the presentation, inclusive of presentation notes is included withthe announcement.
ABOUT ALCIDION GROUP
Alcidion is the brainchild of the former CEO of the SA Heath Department and Professor Malcolm Pradhan, a Stanford qualified physician. Over the past decade, Alcidion has invested $15m into the R&D of the cutting edge Clinical Decision Support System and is now focussed on commercializing the technology.
The introduction of Patient Protection & Affordable Care Act 2010 (“Obamacare”) requires US hospitals to accelerate the adoption of Electronic Medical Records. Alcidion is a leading supplier of these systems in Australia and is now seeking to expand its operations into the United States.
To view the full announcement, please click on the button below.